Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins

Archives of Gerontology and Geriatrics

Volumn 51, Issue 2, 2010, Pages 149-151

  Desai, Harit ^a   Aronow, Wilbert S ^a   Ahn, Chul ^b   Gandhi, Kaushang ^a   Amin, Harshad ^a   Lai, Hoang M ^a   Tsai, Fausan S ^a   Sharma, Mala ^a   Babu, Sateesh ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Abdominal aortic aneurysm repair; Beta blockers; Carotid endarterectomy; Lower extremity revascularization; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GERIATRIC PATIENT; HEART INFARCTION; HUMAN; INCIDENCE; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; VASCULAR SURGERY;

EID: 77955269145     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2009.09.042     Document Type: Article

References (14)

1. Albert M.A., Danielson E., Rifai N., Ridker P.M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized and cohort study. J. Am. Med. Assoc. 2001, 286:64-70.
2. Aronow W.S. Treatment of high-risk older persons with lipid-lowering drug therapy. Am. J. Ther. 2008, 15:102-107.
3. Aronow W.S., Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125mg/dl treated with statins versus no lipid-lowering drug. Am. J. Cardiol. 2002, 89:67-69.
4. Aronow W.S., Ahn C. Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol ≥125mg/dl treated with statins versus no lipid-lowering drug. Am. J. Cardiol. 2002, 90:789-791.
5. Durazzo A.E.S., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leao P., Caramelli B. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J. Vasc. Surg. 2004, 39:967-976.
6. Kertai M.D., Boersma E., Westerhout C.M., Domburg R.V., Klein J., Bax J.J., Van Urk H., Poldermans D. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am. J. Med. 2004, 116:96-103.
7. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
8. O'Driscoll G., Green D., Taylor R.R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997, 95:1126-1131.
9. O'Neil-Callahan K., Katsimaglia M.R., Ryan J., Mosby C., Ioannidis J.P.A., Danias P.G. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. The Statins for Risk Reduction in Surgery (StaRRS) Study. J. Am. Coll. Cardiol. 2005, 45:336-342.
10. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F.L., Thomson I.R., Lansberg P.J., Fleisher L.A., Klein J., Van Urk H., Roelandt J.R.T.C., Boersma E. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003, 107:1848-1851.
11. Rosenson R.S., Tangney C.C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. J. Am. Med. Assoc. 1998, 279:1643-1650.
12. Takemoto M., Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1712-1719.
13. Undas A., Brummel K.E., Musial J., Mann K.G., Szczeklik A. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 2001, 103:2248-2253.
14. Undas A., Brozek J., Musial J. Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease. Clin. Lab. 2002, 48:287-296.